ArriVent BioPharma, Inc. Common Stock

AVBP · NASDAQ
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Assets
Cash & Equivalents$112,672$112,765$49,865$74,293
Short-Term Investments$187,594$122,922$126,212$144,570
Receivables$505$505$505$500
Inventory$0$0$0$0
Other Curr. Assets$20,447$13,957$9,203$0
Total Curr. Assets$321,218$250,149$185,785$226,979
Property Plant & Equip (Net)$49$85$120$154
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$5,108$18,793$29,414$47,683
Tax Assets$0$0$0$0
Other NC Assets$180$479$176$126
Total NC Assets$5,337$19,357$29,710$47,963
Other Assets$0$0$0$0
Total Assets$326,555$269,506$215,495$274,942
Liabilities
Payables$5,933$4,060$4,364$3,782
Short-Term Debt$56$0$0$0
Tax Payable$0$0$0$0
Deferred Revenue$0$0$0$0
Other Curr. Liab.$11,181$2,792$1,549$4,163
Total Curr. Liab.$21,558$19,636$12,953$17,274
LT Debt$0$0$0$0
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$0$0$0$0
Total NC Liab.$0$0$0$14
Other Liabilities$0$0$0$0
Cap. Leases$56$98$138$176
Total Liabilities$21,558$19,636$12,953$17,288
Equity
Pref Stock$0$0$0$0
Common Stock$4$4$4$3
Retained Earnings-$369,097-$334,119-$302,720-$238,333
AOCI$206-$18-$17-$211
Other Equity$0$0$0$0
Total Equity$304,997$249,870$202,542$257,654
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$326,555$269,506$215,495$274,942
Net Debt-$112,616-$112,765-$49,865-$74,293